MSOX is not a stock; it is an actively managed exchange-traded fund (ETF) that uses swap agreements to target about two times the daily total return of MSOS, its unleveraged US cannabis sibling. Because ETFs do not receive conventional sell-side analyst price targets, no credible individual analyst targets or consensus figure exist to average. The $3.00 objective is therefore a fallback target drawn from public discussion and technical context rather than an analyst estimate.
The level is a round psychological milestone that MSOX traded near as recently as early September and early October 2026, and it sits close to where the fund's net asset value (NAV) stood at the end of September, around $2.99. Framed this way, $3.00 represents a return toward recently traded levels, not a new all-time high. It should be read strictly as a publicly discussed objective, not a forecast or a guarantee.
As of late October 2026, MSOX traded near $1.89, close to the lower end of a 52-week range of about $1.62 to $11.88. Reaching $3.00 would require roughly 59% upside, which is a very large move. For a daily-reset leveraged fund, the path matters as much as the distance: because exposure resets each day, a choppy, side-to-side grind can erode value even when the underlying direction is roughly flat, whereas a sustained multi-day rally in MSOS could drive MSOX higher quickly.
MSOX's fortunes are tied almost entirely to US multi-state cannabis operators held through MSOS. A durable advance would likely require a sustained improvement in cannabis equities, not just a single-day bounce, because daily reset mechanics reward extended directional moves.
The clearest support is the possibility of US cannabis reform. Federal rescheduling of cannabis from Schedule I to Schedule III, passage of banking legislation such as the SAFE Banking Act, and relief from Section 280E tax treatment would directly improve the profitability and funding options of the multi-state operators that dominate MSOS and, in turn, MSOX. Any progress on these fronts has historically triggered sharp sector rallies.
The fund's 2x daily leverage also means a genuine sector recovery would be amplified on a daily basis, allowing MSOX to recover lost ground rapidly during strong stretches. Elevated volatility and heavy trading volume show the fund remains a preferred vehicle for traders seeking leveraged exposure to cannabis headlines.
The most significant obstacle is volatility decay. A 2x daily-reset fund can underperform two times its underlying over longer periods when markets are choppy, because losses compound and daily rebalancing works against the holder. MSOX has demonstrated this: its one-year return was deeply negative even relative to a weak cannabis sector.
Costs are also a headwind. The net expense ratio is roughly 0.97%, and the fund's total indirect cost of its swaps, including embedded costs and referenced-asset expenses, was reported near 7.63% in the most recent fiscal year, partly offset by interest on cash collateral. Added to this are sector-specific risks: stalled legislation, ongoing price compression in state markets, and the possibility of further reverse splits, one of which (a 1-for-20 split) occurred in late 2024.
The $1.62 area represents the 52-week low and a key support zone, with the fund repeatedly finding buyers near $1.66 to $1.72 during 2026. The $3.00 objective sits near a prior trading zone and a level the fund tested around the end of September before sliding back. Above that, resistance extends toward the fund's former highs, with the 52-week high of $11.88 remaining far overhead. MSOX continues to trade below its longer-term moving averages, reflecting a persistent downtrend despite occasional sharp rallies.
Because $3.00 is a publicly discussed milestone rather than a published analyst target, it carries no fixed research horizon. Traders should monitor US cannabis regulatory developments, including any rescheduling or banking-reform action, along with the earnings reports of the largest multi-state operators and changes in MSOS itself. Fund flows, NAV premium or discount, and sustained directional momentum in the underlying cannabis index are also important signals, since daily-reset leverage rewards persistence rather than one-off spikes.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a fast-moving leveraged fund like MSOX, where daily reset mechanics and volatility dominate returns, such signals can help traders discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual review. Explore the AI Daily Buy/Sell Signals to see how automated analysis can complement your own research.
The question of whether MSOX can reach $3.00 depends less on valuation than on the direction and persistence of the US cannabis sector, which drives MSOS and, through 2x daily leverage, MSOX. The roughly 59% move required is very large, yet it remains within levels the fund has traded in recent months. Reform catalysts such as rescheduling, banking access, and 280E relief provide a genuine upside case, while volatility decay, elevated costs, leverage, and an entrenched sector downtrend are meaningful counterweights. The $3.00 figure is a publicly discussed milestone, not a forecast, and investors should monitor regulatory news, cannabis operator earnings, fund flows, and technical momentum before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that MSOX and SPXL have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MSOX and SPXL's prices will move in lockstep.
| Ticker / NAME | Correlation To MSOX | 1D Price Change % | ||
|---|---|---|---|---|
| MSOX | 100% | +4.08% | ||
| SPXL - MSOX | 17% Poorly correlated | +0.72% | ||
| SSO - MSOX | 17% Poorly correlated | +0.54% | ||
| TSLL - MSOX | 15% Poorly correlated | +8.64% | ||
| QLD - MSOX | 14% Poorly correlated | +2.55% | ||
| TECL - MSOX | 12% Poorly correlated | +4.24% | ||
More | ||||